Zacks: Brokerages Anticipate Dextera Surgical Inc. (DXTR) Will Post Earnings of -$0.05 Per Share
Equities analysts expect that Dextera Surgical Inc. (NASDAQ:DXTR) will post earnings of ($0.05) per share for the current quarter, Zacks reports. Two analysts have made estimates for Dextera Surgical’s earnings. Dextera Surgical posted earnings per share of ($0.44) in the same quarter last year, which indicates a positive year-over-year growth rate of 88.6%. The firm is expected to announce its next earnings report on Monday, November 6th.
According to Zacks, analysts expect that Dextera Surgical will report full year earnings of ($0.24) per share for the current fiscal year, with EPS estimates ranging from ($0.28) to ($0.20). For the next fiscal year, analysts forecast that the firm will post earnings of ($0.20) per share, with EPS estimates ranging from ($0.20) to ($0.19). Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Dextera Surgical.
Dextera Surgical (NASDAQ:DXTR) last issued its earnings results on Tuesday, August 8th. The medical instruments supplier reported ($0.40) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.11) by ($0.29). The business had revenue of $1.05 million for the quarter, compared to analysts’ expectations of $1.03 million.
A number of equities analysts have commented on DXTR shares. Zacks Investment Research lowered shares of Dextera Surgical from a “hold” rating to a “strong sell” rating in a research report on Tuesday, September 12th. Wedbush reduced their price target on shares of Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating on the stock in a research report on Wednesday, July 12th. Finally, Ladenburg Thalmann Financial Services started coverage on shares of Dextera Surgical in a research report on Wednesday, August 16th. They issued a “buy” rating and a $0.80 price target on the stock.
Shares of Dextera Surgical (DXTR) traded down 0.2202% during trading on Friday, reaching $0.2941. 770,291 shares of the company’s stock were exchanged. Dextera Surgical has a 52-week low of $0.17 and a 52-week high of $2.33. The company has a 50 day moving average price of $0.30 and a 200-day moving average price of $0.51. The company’s market capitalization is $5.23 million.
Large investors have recently added to or reduced their stakes in the business. Perkins Capital Management Inc. acquired a new position in Dextera Surgical in the second quarter valued at about $100,000. Virtu KCG Holdings LLC boosted its position in Dextera Surgical by 1,380.6% in the second quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock valued at $111,000 after buying an additional 344,933 shares in the last quarter. Finally, Broadfin Capital LLC boosted its position in Dextera Surgical by 64.7% in the second quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock valued at $296,000 after buying an additional 388,080 shares in the last quarter. Hedge funds and other institutional investors own 6.58% of the company’s stock.
About Dextera Surgical
Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.